this isn't at you but the below from what you sent. RLFTF should not be pissing one second away worrying about another medicine as they have (or maybe had) the crown jewel. Some will say that will be the way they get to the nasdaq. no one would be rlftf if it made the nasdaq because they have no management team nor anyone that knows anything about managing a lucritive asset.
In the meantime, Relief has partnered with Acer Therapeutics (ACER) to start building a pipeline of drugs beyond Zyesami for some very strange drugs for rare conditions, and they have also been busy ensuring they hold all the patents for aviptadil-related formulations by essentially acquiring all the shares of Advita Life Sciences as they have been working on inhaled formulations of aviptadil as well.
News 
Market Data 
Discover 
AI
